US equities
|
NVDA
$238.51
▲+1.95%
SPCX
$167.09
▲+5.11%
MU
$1,063.48
▼-1.06%
TSLA
$380.30
▲+2.62%
MSFT
$525.50
▲+1.54%
SNDK
$1,708.78
▼-0.65%
INTC
$117.25
▼-1.74%
META
$742.85
▲+2.03%
NVDA
$238.51
▲+1.95%
SPCX
$167.09
▲+5.11%
MU
$1,063.48
▼-1.06%
TSLA
$380.30
▲+2.62%
MSFT
$525.50
▲+1.54%
SNDK
$1,708.78
▼-0.65%
INTC
$117.25
▼-1.74%
META
$742.85
▲+2.03%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Traws Pharma, Inc. - Common Stock
(NQ:
TRAW
)
0.5550
-0.0135 (-2.37%)
Delayed Quote
Updated: 2:32 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Traws Pharma, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Traws Pharma to Host Corporate Update Call on August 15, 2024, at 8:00 AM ET
August 14, 2024
From
Traws Pharma, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
July 04, 2024
Via
Benzinga
Traws Pharma’s ICAR Poster Highlights Potency of COVID-19 Candidate
May 23, 2024
Differentiated resistance profile positions Traws’ program as a potential class leader
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update
May 16, 2024
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy
May 07, 2024
From
Traws Pharma, Inc.
Via
GlobeNewswire
Earnings Scheduled For April 16, 2024
↗
April 16, 2024
Companies Reporting Before The Bell • Traws Pharma (NASDAQ:TRAW) is expected to report earnings for its fourth quarter.
Via
Benzinga
Why Flora Growth Shares Are Trading Lower By Around 20%; Here Are 20 Stocks Moving Premarket
↗
April 04, 2024
Shares of Flora Growth Corp. (NASDAQ: FLGC) fell sharply in today’s pre-market trading after the company reported the launch of proposed underwritten public offering of common shares.
Via
Benzinga
< Previous
1
2
3
4
Next >